Securities code: Yantai Dongcheng Biochemicals Co.Ltd(002675) securities abbreviation: Yantai Dongcheng Biochemicals Co.Ltd(002675) Announcement No.: 2022011 Yantai Dongcheng Biochemicals Co.Ltd(002675)
Announcement on the reply to the notification letter on the preparations for the meeting of the issuance and Examination Committee of non-public offering of shares
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete
False records, misleading statements or material omissions.
Yantai Dongcheng Biochemicals Co.Ltd(002675) (hereinafter referred to as “the company”) recently received the letter on making preparations for the meeting of the stock issuance and Examination Committee of Yantai Dongcheng Biochemicals Co.Ltd(002675) non-public development banks issued by the China Securities Regulatory Commission (hereinafter referred to as “the CSRC”).
The company and relevant intermediaries have carefully studied and implemented the listed issues in accordance with the requirements of the notification letter, and now publicly disclose the contents of the reply according to the requirements. For details, see the reply to the letter on making preparations for the meeting of the stock issuance and Examination Committee of Yantai Dongcheng Biochemicals Co.Ltd(002675) non-public development banks published on cninfo.com on the same day. The company will submit reply materials to the CSRC as required.
The company’s non-public offering of A-Shares needs further approval from the CSRC, and there is still uncertainty about whether it can be approved. According to the progress of the matter, the company will timely perform the obligation of information disclosure in strict accordance with the provisions and requirements of relevant laws and regulations. Please pay attention to the investment risks.
It is hereby announced.
Yantai Dongcheng Biochemicals Co.Ltd(002675) board of directors April 9, 2022
